Stocks · Health care · Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

AQST Clue Score18
United States Fiscal year ends December CIK 0001398733 Results filed 3 Nov 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Peter E. Boyd
14 Jun 2022
SVP-Bus. Process & Info. Tech.
Buy
5,000
$0.81
$4.05K
Lori J Braender
8 Jun 2022
General Counsel
Buy
13,761
$0.96
$13.21K
Peter E. Boyd
8 Jun 2022
SVP-Bus. Process & Info. Tech.
Buy
2,293
$0.96
$2.20K
Alexander Mark Schobel
8 Jun 2022
Chief Innovation/Tech Officer
Buy
45,871
$0.96
$44.04K
Daniel Barber
8 Jun 2022
Chief Executive Officer
Buy
91,743
$0.96
$88.07K
Peter E. Boyd
16 Mar 2020
SVP-Bus. Process & Info. Tech.
Buy
2,000
$1.50
$3.00K
Lori J Braender
16 Mar 2020
SVP, General Counsel
Buy
14,000
$1.54
$21.62K
Daniel Barber
27 Aug 2019
SVP-Chief Operating Officer
Buy
2,000
$3.99
$7.98K
James S Scibetta
21 Aug 2019
Director
Buy
900
$3.81
$3.43K
James S Scibetta
20 Aug 2019
Director
Buy
11,310
$3.80
$43.00K
James S Scibetta
19 Aug 2019
Director
Buy
10,761
$3.77
$40.55K
Keith J Kendall
14 Aug 2019
CEO and President
Buy
1,000
$3.65
$3.65K
Keith J Kendall
14 Aug 2019
CEO and President
Buy
1,000
$3.70
$3.70K
Keith J Kendall
13 Aug 2019
CEO and President
Buy
1,000
$4.05
$4.05K
Peter E. Boyd
12 Aug 2019
SVP-Bus. Process & Info. Tech.
Buy
600
$3.81
$2.29K
Lori J Braender
9 Aug 2019
SVP, General Counsel
Buy
10,000
$4.07
$40.75K
Theresa Wood
9 Aug 2019
SVP-HR and Org. Development
Buy
1,000
$3.99
$3.99K
Keith J Kendall
9 Aug 2019
CEO and President
Buy
2,000
$4.00
$7.99K
Keith J Kendall
9 Aug 2019
CEO and President
Buy
1,000
$3.93
$3.93K
Keith J Kendall
9 Aug 2019
CEO and President
Buy
2,000
$3.84
$7.68K
Daniel Barber
10 Dec 2018
SVP-Chief Strategy/Dev Officer
Buy
1,000
$8.00
$8.00K
Alexander Mark Schobel
10 Dec 2018
Chief Innovation/Tech Officer
Buy
1,000
$7.78
$7.78K
John T. Maxwell
6 Dec 2018
SVP-Chief Financial Officer
Buy
5,000
$8.87
$44.35K
Alexander Mark Schobel
6 Dec 2018
Chief Innovation/Tech Officer
Buy
2,000
$8.69
$17.38K
Keith J Kendall
27 Nov 2018
CEO and President
Buy
1,000
$9.87
$9.87K
Lori J Braender
27 Nov 2018
General Counsel
Buy
1,000
$10.57
$10.57K
Theresa Wood
26 Nov 2018
SVP-HR and Org. Development
Buy
500
$10.34
$5.17K
Keith J Kendall
23 Nov 2018
CEO and President
Buy
1,950
$9.90
$19.31K
Keith J Kendall
21 Nov 2018
CEO and President
Buy
6,000
$10.17
$61.02K
Peter E. Boyd
21 Nov 2018
SVP-Operations/Value Delivery
Buy
200
$9.98
$2.00K
John T. Maxwell
21 Nov 2018
SVP-Chief Financial Officer
Buy
10,000
$9.80
$98.00K
Alexander Mark Schobel
21 Nov 2018
Chief Innovation/Tech Officer
Buy
1,000
$10.25
$10.25K
Ken W. Marshall
21 Nov 2018
Commercial Leader
Buy indirect
1,445
$10.15
$14.67K
Douglas K Bratton
24 Jul 2018
Director
Buy indirect
165,000
$15.00
$2.48M

What was left out

Form 4 filings counted 284
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 4
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 11,746,136
Sales filed before the plan box existed 9
History held since 26 Jul 2018